CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AE0. A total of 10 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,935,000 | -69.8% | 3,300,000 | -64.5% | 0.06% | -69.0% |
| Q2 2021 | $9,716,000 | -7.8% | 9,300,000 | 0.0% | 0.20% | -42.7% |
| Q1 2021 | $10,539,000 | +31.5% | 9,300,000 | 0.0% | 0.34% | +36.5% |
| Q4 2020 | $8,015,000 | -9.5% | 9,300,000 | 0.0% | 0.25% | -31.3% |
| Q3 2020 | $8,861,000 | – | 9,300,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 64,842,000 | $63,520,000 | 3.42% |
| QVT Financial LP | 15,000,000 | $14,638,000 | 1.79% |
| ARISTEIA CAPITAL, L.L.C. | 22,150,000 | $21,214,000 | 0.87% |
| WHITEBOX ADVISORS LLC | 9,300,000 | $8,861,000 | 0.37% |
| LMR Partners LLP | 13,099,000 | $12,793,000 | 0.26% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,100,000 | $5,842,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 1,500,000 | $1,442,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 2,025,000 | $1,982,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,968,000 | $1,875,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |